Why Making Dramatic Moves: Dean Foods Company (NYSE:DF), Baidu Inc (ADR) (NASDAQ:BIDU), Merck & Co. Inc. (NYSE:MRK), Coffee Holding Company (NASDAQ:JVA), JRN

Dean Foods Company (NYSE:DF), the largest U.S. milk processor, forecast its first quarterly adjusted profit in a year, citing cost cuts and a steep fall in butterfat prices. The company, whose shares rose 13.7 percent yesterday to close at $16.40, also reported an adjusted third-quarter loss that was smaller than expected. This was the first time in seven quarters that the maker of Meadow Gold and Dean’s Milk beat the average analyst estimate on its earnings. Dean Foods Company (NYSE:DF) belongs to Consumer Goods sector. Its net profit margin is 4.00% and weekly performance is 17.56%. On last trading day company shares ended up $16.40. Dean Foods Company (NYSE:DF) distance from 50-day simple moving average (SMA50) is 15.12%.

Baidu Inc (NASDAQ:BIDU) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.90 EPS for the quarter, missing the Thomson Reuters consensus estimate of $9.83 by $7.93. The company had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $13.55 billion. During the same quarter in the prior year, the company posted $1.41 earnings per share. Analysts expect that Baidu Inc will post $38.20 EPS for the current fiscal year. Baidu Inc (ADR) (NASDAQ:BIDU)’s stock on 10 November traded at beginning with a price of $237.30 and when day-trade ended the stock finally advanced 4.67% to end at $247.58. Baidu Inc (ADR) (NASDAQ:BIDU)’s showed weekly performance of 4.67%.

Merck & Co. Inc. (NYSE:MRK) presented interim data from a proof-of-concept (C-SWIFT) study on its fixed-dose combination regimen – grazoprevir/elbasvir (MK-5172/MK-8742, MK-5172A) plus Gilead’s (GILD) Sovaldi (sofosbuvir – a nucleotide inhibitor) – for the treatment of chronic hepatitis C virus (:HCV) infection. The data was presented at the annual meeting of the American Association for the Study of Liver Diseases (AASL). Merck & Co. Inc. (NYSE:MRK)’s stock on 10 November traded at beginning with a price of $58.24 and when day-trade ended the stock finally fell -0.89% to end at $58.81. Merck & Co. Inc. (NYSE:MRK)’s showed weekly performance of -0.19%.

Coffee Holding Co. (NYSE:JVA) CEO Andrew Gordon purchased 10,000 shares of the company’s stock on the open market in a transaction that occurred on Tuesday, October 14th. The shares were purchased at an average price of $5.48 per share, with a total value of $54,800.00. Coffee Holding Company, Inc. (NASDAQ:JVA) ended the last trading day at $5.62. Company weekly volatility is calculated as 1.89% and price to cash ratio as 10.36. Coffee Holding Company, Inc. (NASDAQ:JVA) showed a weekly performance of -1.92%.

Journal Communications, Inc. (NYSE:JRN) on 30 October 2014 announced results for its third quarter ended September 28, 2014. Revenue of $105.1 million, up 8.5%. Television revenue of $47.9 million, up 22.8%. Television retransmission revenue of $9.6 million, up 82.0%. Radio revenue of $21.6 million, up 5.1%. Digital revenue of $5.0 million, up 9.9%. Operating earnings of $14.2 million, up 40.4%. Diluted EPS of $0.14, compared to $0.09. “We are pleased to report that Journal Communications third quarter revenue of $105 million grew more than 8%, driving an operating earnings increase of 40%. Earnings per share in the quarter were $0.14 compared to $0.09 last year,” said Steven J. Smith, Chairman and CEO of Journal Communications. Journal Communications Inc. (NYSE:JRN) shares increased 2.63% in last trading session and ended the day at $9.37. JRN Gross Margin is 46.50% and its return on assets is 7.80%. Journal Communications Inc. (NYSE:JRN) quarterly performance is 2.18%.